Kelly Hunt to Aromatase Inhibitors
This is a "connection" page, showing publications Kelly Hunt has written about Aromatase Inhibitors.
Connection Strength
0.571
-
Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance). J Clin Oncol. 2017 Apr 01; 35(10):1061-1069.
Score: 0.571